Evidence map›Paper›PMID 42584890›Full record

Trial reportJAMA network open2026

Differences in Cognitive Aging Assessments Associated With Retest Effects.

Yan Wang, James Russell Pike, Jennifer A Deal, Frank R Lin, Nicholas Salvatore Reed, Emmanuel E Garcia-Morales, Alison R Huang, Douglas A Jabs, Alden L Gross

Abstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yan WangDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
James Russell PikeDivision of Epidemiology, Department of Population Health, New York University Grossman School of Medicine, New York.
Jennifer A DealDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Frank R LinCochlear Center for Hearing and Public Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Nicholas Salvatore ReedDivision of Epidemiology, Department of Population Health, New York University Grossman School of Medicine, New York.
Emmanuel E Garcia-MoralesDivision of Epidemiology, Department of Population Health, New York University Grossman School of Medicine, New York.
Alison R HuangDivision of Epidemiology, Department of Population Health, New York University Grossman School of Medicine, New York.
Douglas A JabsDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Alden L GrossDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Retest effects can inflate longitudinal cognitive test performance and complicate estimation of cognitive change. Whether retest effects influence estimated intervention effects in randomized clinical trials remains unclear. Objective: To quantify the magnitude and heterogeneity of differences associated with retesting in longitudinal cognitive testing and examine whether accounting for retesting alters estimated treatment effects in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) trial. Design, Setting, and Participants: This cohort study was an ad hoc secondary analysis of ACHIEVE, a multicenter phase 3 randomized clinical trial conducted from 2017 to 2022 with 3-year follow-up. Community-dwelling older adults with untreated hearing loss were enrolled at 4 US community sites: Forsyth County, North Carolina; Jackson, Mississippi; Minneapolis, Minnesota; and Washington County, Maryland. Analyses were completed in November 2025. Exposure: Cognitive retesting, defined as a binary indicator (0 for baseline visit; 1 for follow-up visits). Main Outcomes and Measures: The primary outcome was a global cognitive factor score derived from a neurocognitive battery. Secondary outcomes included domain-specific factor scores (language, executive function, memory) and individual test scores. Retest differences were estimated using linear mixed-effects models adjusted for covariates consistent with the main ACHIEVE analysis. Interactions tested whether retest differences varied by key factors. Model-based trajectories and intervention-control estimates were compared with and without retest adjustment. Results: A total of 977 older adults (mean [SD] baseline age, 76.3 [4.0] years; 523 [54%] female) contributed 2571 in-person cognitive assessments , including 552 adults (57%) with mild hearing loss and 739 adults (76%) recruited de novo. Retest differences were significant for global cognition (β = 0.11; 95% CI, 0.07 to 0.15), executive function (β = 0.15; 95% CI, 0.10 to 0.20), and memory (β = 0.12; 95% CI, 0.06 to 0.18), approximately offsetting 1 year of model-estimated age-related cognitive decline. Language showed minimal retest differences (β = -0.03; 95% CI, -0.08 to 0.02). Retest differences did not meaningfully vary by hearing loss severity, trial intervention, or recruitment source. Retest adjustment altered estimated cognitive trajectories but did not meaningfully alter intervention outcomes. Conclusions and Relevance: This cohort study found that retest differences were substantial for global cognition, executive function, and memory but did not meaningfully alter estimated hearing intervention outcomes. Adjustment for retest differences is recommended to improve interpretation and intervention estimation in longitudinal cognitive studies.

Indexed as

Cognitive AgingNeuropsychological TestsAgedAged, 80 and overAgingCognitionCohort StudiesFemaleHumansMale

Identifiers

PMID42584890
PMCPMC13470289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.